6Global Initiative for Chronic Obstructive Lung Disease.Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease.NHLBI/WHO workshop report. Bethesda, National Heart,Lung and Blood Institute, April 2001; Update of theManagement Sections, GOLD website (www.goldcopd.com). Date updated: 1 July 2003.
7Rybicki BA, Beaty TH, Cohen BH. Major genetic mechanisms in pulmonary function[J]. J Clin Epidemiol,1990,43(7):667-675.
8Silverman EK, Chapman HA, Drazen JM, et al. Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease. Risk to relatives for airflow obstruction and chronic bronchitis[J]. Am J Respir Crit Care Med,1998,157[6 Pt 1]: 1770-1778.
9Dahl M,Tybjaerg-Hansen A,Lange P,et al. Change in lung function and morbidity from chronic obstructive pulmonary disease in alpha1-antitrypsin MZ heterozygotes: A longitudinal study of the general population[J]. Ann Intern Med,2002,136 (4):270-279.
10Montano M, Beccerril C, Ruiz V,et al Matrix metalloproteinases activity in COPD associated with wood smoke[J]. Chest, 2004,125(2):466-472.
